Search results
Health Canada authorizes Alecensaro® (alectinib) as the first and only adjuvant treatment for people...
CNW· 3 days ago/CNW/ - Hoffmann-La Roche Limited (Roche Canada) is pleased to announce that on June 27, 2024, Health Canada granted approval of Alecensaro® (alectinib)...